Growing pain killers

24 October 2016

The MedTech and Pharma Growth Centre will invest $7.4 million over two years in 14 national industry-led projects.

The offered funding will need to be matched dollar-for-dollar by project partners, and could leverage an estimated $32 million in total investment.

Selected from 38 applications, the 14 funded projects are expected to creatively address some of the barriers that constrain the growth of Australia's medtech and pharmaceuticals sector.

According to MTPConnect chief executive officer Sue MacLeman, these include a lack of collaboration between business and research, skills shortages, the need for more focused funding and investment, and the need for more streamlined and harmonised regulatory and market access frameworks.

The successful applicants include:

More information: